Termination of Pregnancy
* Indications for medical abortion:
I. Have intrauterine pregnancy and meet the criteria of medical
abortion.
II. Are able and willing to have a surgical abortion if
medication fails.
III. Understand the protocol and consent form.
IV. Do not have a contraindication to the drugs used.
< Recommendations for Termination in First Trimester >
- Medical methods:
- Misoprostol (PGE1 analogue)
800��g for vaginal administration
every 24-48 hours, up to 3 doses
(up to 56-84 days )
- Mifepristone in combination with prostaglandin:
Mifepristone single oral dose of 600mg
Misoprostol 800��m vaginally
at 36-48 hours
(up to 63 days )
- Surgical methods:
Suction D & C
à The preparation of
cervix with hydrophilic dilators, prostaglandins,
or mifepristone can enhance the safety and efficacy.
(esp: nulliparous: > 9wk; all women: > 12wk )
< Recommendations for Termination in Second Trimester>
- Medical methods:
- Vaginal prostaglandin:
- Gemeprost: (PGE1 analogue)
1mg for vaginal pessary every 3 hours on up to 2
occasions in the first 24 hours and repeated the next day if
necessary.
- Misoprostol: (PGE1 analogue)
I. 200��g inserted
intracervically or vaginally q12h (13–27 weeks )
II. 800��g inserted
vaginally (13-28weeks )
- Extra-amniotic injection of prostaglandin:
- Dinoprost (PGF2��n�w��
- Insertion of Foley catheter into intrauterine cavity and inject N/S
50cc in to Foley to fix it.
- Dilute 1 vial PGF2�� (5mg/1cc) with N/S
4cc
- PGF2�� 1mg/cc + N/S 3cc and injected
this mixture 1cc into the Foley followed by N/S 5cc, if patient’s
condition is stable, inject the remaining 3cc mixture following by N/S
5cc 30min later.
- PGF2�� 1mg/cc + N/S 3cc and injected
this mixture into the Foley followed by N/S 5cc q1h X
4 times.
- Surgical methods:
- Dilatation and evacuation (D&E):
Cervical preparation before abortion is needed.
- Hysterotomy :
This method is only necessary when abortion cannot be achieved
safely through the vagina, uterine injury or hemorrhage during the abortion.
- Hysterectomy
< Contraindications of Prostaglandins >
Bronchial asthma, severe cardiovascular disease, severe renal or
liver diseases, cerebral convulsion, glaucoma (precaution with previous uterine
surgery).
< References >
- Medical methods for termination of pregnancy. Report of a WHO Scientific
Group.
WHO Technical Report Series. 1997; 871: I-vii, 1-110
- Medical abortion in early pregnancy: A review of the evidence.
Obstect Gynecol 1997; 89: 790-6
3. Misoprostol used alone for the termination of early
pregnancy
Contraception 1999; 59: 209-217
|